Vanessa Jacoby

Director/Miembro de la Junta en SONOMA PHARMACEUTICALS, INC. .

Health Technology

Commercial Services

Consumer Services

Perfil

Vanessa Lusitano Jacoby is currently an Independent Director at Sonoma Pharmaceuticals, Inc. since 2026 and Chief Financial & Business Officer at Quanta Therapeutics, Inc. Former roles include Vice President-Finance at PharmAkea, Inc. from 2014 to 2019, Senior Manager-Finance at Artes Medical, Inc. in 2008, Accounting Director & Controller at BrainCells, Inc., Performance Analyst at Nicholas-Applegate Capital Management, Auditor at Ernst & Young LLP, and Revenue Manager at Diversa Corp.
Education includes an MBA from National University conferred in 2003 and an undergraduate degree from Fundação Armando Alvares Penteado conferred in 1998.

Cargos activos de Vanessa Jacoby

Empresas	Cargo	Inicio
SONOMA PHARMACEUTICALS, INC.	Director/Miembro de la Junta	28/01/2026
Quanta Therapeutics, Inc. Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric inhibitors for RAS-driven cancers	Director Financiero/CFO	-

Todos los cargos activos de Vanessa Jacoby

Antiguos cargos conocidos de Vanessa Jacoby.

Empresas	Cargo	Fin
PharmAkea, Inc. PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases	Director Financiero/CFO	01/01/2019
Artes Medical, Inc. Artes Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures, commercializes of injectable aesthetic products for dermatology and plastic surgery markets	Corporate Officer/Principal	01/01/2008
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Corporate Officer/Principal	-
Nicholas-Applegate Capital Management Nicholas-Applegate Capital Management Investment ManagersFinance Nicholas-Applegate Capital Management employs a forward-thinking, change-focused investment philosophy to create domestic and international portfolios across fundamental and systematic equity, income and growth strategies. The firm's investment approach seeks to identify points of inflection that could lead to strong price appreciation and to invest in a timely manner to maximize return potential. The firm's range of investment strategies include domestic, global, international and specialty portfolios. Each portfolio follows one of two approaches: traditional or model-driven (systematic). Nicholas-Applegate tends to invest in the stocks of companies in the electronic technology, health technology, technology services, consumer non-durables and finance sectors. The firm invests globally, across all market-caps. Nicholas-Applegate maintains a medium turnover rate.	Corporate Officer/Principal	-
Diversa Corp. Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops genomic tools and biological technology for the agricultural industry	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Vanessa Jacoby.

Formación de Vanessa Jacoby.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Vanessa Jacoby.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	10
Nicholas-Applegate Capital Management Nicholas-Applegate Capital Management Investment ManagersFinance Nicholas-Applegate Capital Management employs a forward-thinking, change-focused investment philosophy to create domestic and international portfolios across fundamental and systematic equity, income and growth strategies. The firm's investment approach seeks to identify points of inflection that could lead to strong price appreciation and to invest in a timely manner to maximize return potential. The firm's range of investment strategies include domestic, global, international and specialty portfolios. Each portfolio follows one of two approaches: traditional or model-driven (systematic). Nicholas-Applegate tends to invest in the stocks of companies in the electronic technology, health technology, technology services, consumer non-durables and finance sectors. The firm invests globally, across all market-caps. Nicholas-Applegate maintains a medium turnover rate.	Finance
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Commercial Services
Diversa Corp. Diversa Corp. Miscellaneous Commercial ServicesCommercial Services Researches and develops genomic tools and biological technology for the agricultural industry	Commercial Services
Sonoma Pharmaceuticals, Inc. Sonoma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and sells stabilized hypochlorous acid	Health Technology
BrainCells, Inc. BrainCells, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs	Health Technology
PharmAkea, Inc. PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drug candidates against protein targets involved in fibroproliferative diseases	Health Technology
Artes Medical, Inc. Artes Medical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures, commercializes of injectable aesthetic products for dermatology and plastic surgery markets	Health Technology
National University National University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Fundação Armando Alvares Penteado Fundação Armando Alvares Penteado Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Quanta Therapeutics, Inc. Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric inhibitors for RAS-driven cancers	Health Technology